• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit polyclonal to Complement C3 beta chain

Background It’s been shown in in-vitro tests that “withdrawal” of tamoxifen

October 1, 2018 by Katherine Lewis Leave a Comment

Background It’s been shown in in-vitro tests that “withdrawal” of tamoxifen inhibits development of tumor cells. second to tenth Rabbit polyclonal to Complement C3 beta chain type of treatment pursuing prior endocrine therapy using tamoxifen (n = 10), an aromatase inhibitor (n = 5), megestrol acetate (n = 1) or fulvestrant (n = 1). Ten … [Read more…]

Posted in: Blogging Tagged: buy TIC10, Rabbit polyclonal to Complement C3 beta chain

Myotonic Dystrophy 1 (DM1) is a genetic disease caused by expansion

August 11, 2017 by Katherine Lewis Leave a Comment

Myotonic Dystrophy 1 (DM1) is a genetic disease caused by expansion of CTG repeats in DNA. 11 UU RNA internal loops, revealing that 11 UU 179411-94-0 supplier base pairs are dynamic and strongly prefer the conformation. Two 2D PMF surfaces were calculated for the 11 UU base pairs, revealing several local minima and three ? … [Read more…]

Posted in: Blogging Tagged: 179411-94-0 supplier, Rabbit polyclonal to Complement C3 beta chain

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by